X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Tata Investment Corporation with Indoco Remedies - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TATA INVEST. CORP. vs INDOCO REMEDIES - Comparison Results

TATA INVEST. CORP.    Change

Tata Investment Corporation is more than 70 years old. It is a non banking financial company (NBFC). The stated objective of the company is to invest in Tata and non-Tata companies, both in the listed and unlisted categories. However, investments in ... More

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TATA INVEST. CORP. INDOCO REMEDIES TATA INVEST. CORP./
INDOCO REMEDIES
 
P/E (TTM) x 19.7 37.9 52.0% View Chart
P/BV x 2.0 3.0 66.4% View Chart
Dividend Yield % 2.2 0.8 289.8%  

Financials

 TATA INVEST. CORP.   INDOCO REMEDIES
EQUITY SHARE DATA
    TATA INVEST. CORP.
Mar-14
INDOCO REMEDIES
Mar-17
TATA INVEST. CORP./
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs505360 140.1%   
Low Rs348249 139.5%   
Sales per share (Unadj.) Rs39.6119.0 33.2%  
Earnings per share (Unadj.) Rs33.88.4 404.3%  
Cash flow per share (Unadj.) Rs33.815.2 222.1%  
Dividends per share (Unadj.) Rs17.001.60 1,062.5%  
Dividend yield (eoy) %4.00.5 759.6%  
Book value per share (Unadj.) Rs390.370.7 552.0%  
Shares outstanding (eoy) m55.1092.15 59.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x10.82.6 420.9%   
Avg P/E ratio x12.636.4 34.6%  
P/CF ratio (eoy) x12.620.0 63.0%  
Price / Book Value ratio x1.14.3 25.3%  
Dividend payout %50.319.1 262.8%   
Avg Mkt Cap Rs m23,48928,083 83.6%   
No. of employees `000NA6.0 0.0%   
Total wages/salary Rs m782,167 3.6%   
Avg. sales/employee Rs ThNM1,817.0-  
Avg. wages/employee Rs ThNM359.0-  
Avg. net profit/employee Rs ThNM127.7-  
INCOME DATA
Net Sales Rs m2,18010,968 19.9%  
Other income Rs m2440 59.4%   
Total revenues Rs m2,20311,007 20.0%   
Gross profit Rs m2,0211,565 129.2%  
Depreciation Rs m1633 0.2%   
Interest Rs m062 0.0%   
Profit before tax Rs m2,044909 224.7%   
Minority Interest Rs m-10-   
Prior Period Items Rs m1120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m292139 210.5%   
Profit after tax Rs m1,863771 241.7%  
Gross profit margin %92.714.3 650.0%  
Effective tax rate %14.315.3 93.7%   
Net profit margin %85.57.0 1,216.3%  
BALANCE SHEET DATA
Current assets Rs m2,6765,725 46.8%   
Current liabilities Rs m1,1885,454 21.8%   
Net working cap to sales %68.32.5 2,766.8%  
Current ratio x2.31.0 214.7%  
Inventory Days Days062 0.0%  
Debtors Days Days372 4.1%  
Net fixed assets Rs m1365,307 2.6%   
Share capital Rs m551184 299.0%   
"Free" reserves Rs m16,3736,331 258.6%   
Net worth Rs m21,5066,516 330.1%   
Long term debt Rs m01,323 0.0%   
Total assets Rs m22,73611,970 189.9%  
Interest coverage xNM15.6-  
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.10.9 10.5%   
Return on assets %8.27.0 117.8%  
Return on equity %8.711.8 73.2%  
Return on capital %10.012.4 80.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m04,507 0.0%   
Fx outflow Rs m01,141 0.0%   
Net fx Rs m03,366 0.0%   
CASH FLOW
From Operations Rs m840886 94.7%  
From Investments Rs m-451-1,706 26.4%  
From Financial Activity Rs m-1,0321,316 -78.4%  
Net Cashflow Rs m-643497 -129.5%  

Share Holding

Indian Promoters % 73.0 59.2 123.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.5 12.5 36.0%  
FIIs % 1.5 6.0 25.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.0 22.4 93.8%  
Shareholders   25,758 12,805 201.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TATA INVEST. CORP. With:   STC INDIA  TVS SRICHAKRA  ADANI PORTS & SEZ  RELIGARE ENT.  CHOLAMANDALAM INVEST.  



Today's Market

Sensex Slumps Over 290 Points; Realty and PSU Stocks Witness Selling(Closing)

After opening the day on a negative note, share markets in India continued their downtrend throughout the day and ended in red.

Related Views on News

TATA INVEST. CORP. Announces Quarterly Results (4QFY18); Net Profit Up 161.0% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, TATA INVEST. CORP. has posted a net profit of Rs 421 m (up 161.0% YoY). Sales on the other hand came in at Rs 583 m (up 62.8% YoY). Read on for a complete analysis of TATA INVEST. CORP.'s quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY18); Net Profit Up 14.3% (Quarterly Result Update)

Jun 19, 2018 | Updated on Jun 19, 2018

For the quarter ended March 2018, INDOCO REMEDIES has posted a net profit of Rs 205 m (up 14.3% YoY). Sales on the other hand came in at Rs 3 bn (down 2.6% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

CreditAccess Grameen IPO: Should You Apply to this Interesting Microfinance Play? (IPO)

Aug 7, 2018

Should you apply to the IPO of CreditAccess Grameen Ltd?

HDFC AMC IPO: Do Valuations Leave Enough on Table for Investors? (IPO)

Jul 20, 2018

Should you subscribe to the IPO of HDFC AMC Ltd?

IndoStar Capital Finance IPO: Is This NBFC Worth Betting On? (IPO)

May 8, 2018

Should you apply for the IPO of IndoStar Capital Finance?

More Views on News

Most Popular

In a Crisis, if Petrol Prices Hit Rs 100, This Stock Could Be a Good Buy(The 5 Minute Wrapup)

Sep 6, 2018

The rise in the crude oil price is a major reason for the fall in the market. If crude oil prices keep on rising, what will happen to stocks?

As the Rupee Takes a Record Plunge, These Pharma Stocks Gain the Most(Sector Info)

Sep 5, 2018

Most pharma stocks were trading with gains amid rupee's fresh fall. Does that mean pharma stocks are back in vogue?

Why Arun Jaitley's Demonetisation Defence Doesn't Add Up(Vivek Kaul's Diary)

Sep 5, 2018

The tax collected has gone up a little but the question is at what cost.

The Cream of Small Cap Stocks(Profit Hunter)

Sep 5, 2018

Akin to skimming the cream off milk, one needs to learn to skim the cream off small cap stocks.

The Secret Of Mirae Asset India Equity Fund's Increasing Popularity(Outside View)

Sep 7, 2018

The prudent investment strategies followed at the fund house has helped Mirae Asset India Equity Fund earn a tag of being a consistent performer, which is in turn gaining popularity among investors.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TATA INVEST. CORP. SHARE PRICE


Sep 18, 2018 (Close)

TRACK TATA INVEST. CORP.

  • Track your investment in TATA INVEST. CORP. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TATA INVEST. CORP.

TATA INVEST. CORP. 8-QTR ANALYSIS

COMPARE TATA INVEST. CORP. WITH

MARKET STATS